Significance of individual management plan for the patients with hereditary lymphangioedema during pregnancy and lactation, and in newborns
Hereditary angioedema (HAE) is a genetically caused orphan disease with a high risk of developing life-threatening attacks, thus requiring availability for up-to-date information on this problem for the doctors of any specialties. A limited number of observations determine the value of the analysis...
Main Authors: | E. N. Bobrikova, A. R. Denisova, T. S. Kotomina, S. A. Serdotetskova, D. S. Fomina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2020-05-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1930 |
Similar Items
-
Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
by: Natalia Gabriel, et al.
Published: (2022-02-01) -
Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasma-derived C1-inhibitor concentrate: a case report
by: D. V. Demina, et al.
Published: (2021-01-01) -
Personalized biological treatment with lanadelumab in a patient with recurrent attacks of hereditary angioedema
by: Artur Gęsicki, et al.
Published: (2024-08-01) -
Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01) -
Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability
by: Diaz-Menindez M, et al.
Published: (2023-03-01)